Back
Enlivex Therapeutics Ltd. Stock Predictions
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
54
ENLV
Enlivex Therapeutics Ltd.
Last Price:
$1.20
Seasonality Move:
5.29%
7 Day Trial
ALL ACCESS PASS
$
7
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiEnlivex Therapeutics Ltd. Stock Forecast
-
Is Enlivex Therapeutics Ltd. Stock Undervalued?The current Enlivex Therapeutics Ltd. [ENLV] share price is $1.16. The Score for ENLV is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
ENLV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Enlivex Therapeutics Ltd. Stock Go Up Next Year?
Data Unavailable
Enlivex Therapeutics Ltd. Stock Rating
Data Unavailable
Enlivex Therapeutics Ltd. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Israel
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
enlivex.com
52-Week Data
52-Week High:
2.10
52-Week Low:
0.83
Prediction Charts
Market Cap:
28.2M
Price in USD:
1.16
Volume:
940.2K
Beta:
1.22
Technical Analysis
SMA50:
1.04
SMA100:
1.13
SMA200:
1.08
52-Wk Change:
-10.77%
Stock Predictions
-
Is Enlivex Therapeutics Ltd. stock public?Yes, Enlivex Therapeutics Ltd. is a publicly traded company.
-
What is the Enlivex Therapeutics Ltd. stock quote today?The Enlivex Therapeutics Ltd. stock price is 1.16 USD today.
-
How to buy Enlivex Therapeutics Ltd. stock online?You can buy Enlivex Therapeutics Ltd. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 0.97 | 0.99 | 1.00 | 0.97 |
| Nov-17 | 0.97 | 0.98 | 1.00 | 0.97 |
| Nov-18 | 0.97 | 0.98 | 1.00 | 0.96 |
| Nov-19 | 0.98 | 0.94 | 0.99 | 0.92 |
| Nov-20 | 0.94 | 0.91 | 0.97 | 0.91 |
| Nov-21 | 0.91 | 0.90 | 0.94 | 0.83 |
| Nov-24 | 1.60 | 1.02 | 1.81 | 1.00 |
| Nov-25 | 0.99 | 0.98 | 1.02 | 0.90 |
| Nov-26 | 1.02 | 0.90 | 1.06 | 0.88 |
| Nov-28 | 0.94 | 0.97 | 0.98 | 0.90 |
| Dec-1 | 0.96 | 0.92 | 0.96 | 0.89 |
| Dec-2 | 0.95 | 0.95 | 0.97 | 0.91 |
| Dec-3 | 0.96 | 1.09 | 1.14 | 0.96 |
| Dec-4 | 1.06 | 1.16 | 1.18 | 1.06 |
Enlivex Therapeutics Ltd. Earnings
Data Unavailable
Enlivex Therapeutics Ltd. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.07 per share, and a decrease next year of $0.00 per share.
* Enlivex Therapeutics Ltd. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.